Unknown PHASE1 INTERVENTIONAL 2-arm NCT04474340

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients: Multicenter Interventional Study

Sponsor: Ministry of Health, Kuwait

Conditions Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia Pneumonia, Viral

Interventions COVID-19 Convalscent Plasma

Updated 6 times since 2020 Last updated: Jul 17, 2020 Started: May 21, 2020 Primary completion: Sep 30, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04474340, this PHASE1 trial focuses on Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia and Pneumonia, Viral and remains ongoing. Sponsored by Ministry of Health, Kuwait, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Sep 2022 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jan 2021 — Sep 2022 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Aug 2020 — Jan 2021 [monthly]

Recruiting PHASE1

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, Kuwait

Data source: Ministry of Health, Kuwait

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuwait City, Kuwait